European Prevention of Alzheimers Dementia Consortium (EPAD)
European Commission FP7-IMI-Seventh Framework Programme/Innovative Medicines Initiative
Alzheimer's disease & other dementias
There is an urgent need for new treatments for Alzheimers disease. The number of people affected worldwide is expected to reach over 100 million by 2050, yet despite intensive efforts over many years, there is still no cure for Alzheimers and little in the way of treatments. Today, research increasingly focuses on ways to prevent the onset of Alzheimers in the first place. The EPAD project is pioneering a novel, more flexible approach to clinical trials of drugs designed to prevent Alzheimers dementia. Using an adaptive trial design should deliver better results faster and at lower cost.